However, a localized raphe-specific effect of chronic SSRIs appears to be the case for the 5-HT1A receptor, with changes in binding exclusively in the raphe nuclei in MDD patients after 6 weeks of SSRI treatment (Gray et al., 2013). This evidence concerns the gene HTR1A and major depressive disorder.